Table 5. Complete Remission Rate by... | American Society of Hematology

Table 5.

Complete Remission Rate by Disease Status, Cytogenetic Status, and MDR1 Expression

MDR1 Expression	Secondary AML
	Unfavorable			Intermed/Favorable			De Novo AML
	Pts	CRs	%CR	Pts	CRs	%CR	Unfavorable			Intermed/Favorable
							Pts	CRs	%CR	Pts	CRs	%CR
Bright/moderate positive (≥0.15)	15	2	13	9	1	11	17	4	24	40	19	48
Dim positive (0.10-0.14)	2	0	0	3	1	33	6	3	50	16	10	63
Negative (<0.10)	2	0	0	7	4	57	2	0	0	27	22	81

MDR1 Expression	Secondary AML
	Unfavorable			Intermed/Favorable			De Novo AML
	Pts	CRs	%CR	Pts	CRs	%CR	Unfavorable			Intermed/Favorable
							Pts	CRs	%CR	Pts	CRs	%CR
Bright/moderate positive (≥0.15)	15	2	13	9	1	11	17	4	24	40	19	48
Dim positive (0.10-0.14)	2	0	0	3	1	33	6	3	50	16	10	63
Negative (<0.10)	2	0	0	7	4	57	2	0	0	27	22	81

Results for 146 patients with complete clinical and biologic data.

Abbreviation: Pts, patients.